Translational Neuroscience Optimization of GlyT1 Inhibitor

Clinical trial NCT01911676 · COMPLETED

Trial details

NCT number: NCT01911676
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cognitive Impairments Associated With Schizophrenia

Start date: 2013-08-01
Primary completion: 2018-12-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.